Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) — The “Autoimmune Disease Diagnostics: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The global autoimmune disease diagnostics market was valued at nearly $14.2 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 3.9%, reaching $17.9 billion by 2028. A worldwide technological advancement in detecting autoimmune diseases fuels growth in this market. In 2022, the enzyme-linked immunosorbent assay (ELISA) segment held the highest market share at about 31.5%, followed by Indirect immunofluorescence (IIF) at 26.4% and immunoblot at 20.2%.
This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.
The report includes:
- 41 data tables and 30 additional tables
- An overview of the global market landscape related to the autoimmune disease diagnostics
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to autoimmune disease diagnostics, accompanied by a comprehensive market share analysis categorized by technology, indication, gender, and geographical region
- Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
- Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
- Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
- Coverage of emerging technologies in autoimmune disease diagnostics, recent developments, future opportunities, patent review, and ESG trends
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, including Abbott, Beckman Coulter Inc., BioMerieux, Siemens Healthcare, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific
Key Attributes
| Report Attribute | Details |
| No. of Pages | 110 |
| Forecast Period | 2023-2028 |
| Estimated Market Value (USD) in 2023 | $14.8 Billion |
| Forecasted Market Value (USD) by 2028 | $17.9 Billion |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/hpggey
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Autoimmune Disease Diagnostics Market
